Goldman Sachs says WeightWatchers' latest deal could revive the company and help it bring in $1.4 billion by 2025
Launched in 2021, Sequence prescribes weight-loss drugs like Ozempic and Wegovy online while helping patients navigate reimbursement and insurance.
Goldman Sachs estimates that sales for obesity drugs like GLP-1s could reach $30 billion annually by 2032. Analysts said in a Monday note that the potential market for such treatments is around 15 million people in the US today, a number that could grow to 31 million in 2030.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
WeightWatchers' stock soars after Sequence deal closesWW International, Inc. announced that it completed an acquisition of Sequence, a virtual clinic that offers access to healthcare providers specializing in chronic weight management.
Les mer »
Goldman Sachs downgrades this commercial real estate stock on difficult macro environmentThis commercial real estate stock isn't likely to recover this year on higher interest rates and stiff free cash flow, Goldman Sachs says
Les mer »
Weight Watchers parent’s stock soars after deal to buy weight-management drugs prescriber Sequence closesShares of WW International Inc. which was formerly known as Weight Watchers, soared 25.2% toward a five-week high in premarket trading Tuesday, after the...
Les mer »
Investors who think recession fears are overblown should buy this lending stock, JPMorgan saysJPMorgan said the stock is a way to express that 'the recession for which investors have been bracing for well over a year, will be milder than feared.'
Les mer »
Weight Watchers parent’s stock soars after deal to buy weight-loss drug prescriber Sequence closesThis deal seems to be tipping the scales in Weight Watchers’ favor, as the parent stock was soaring Tuesday morning off a deal to acquire Sequence, a weight-loss drug prescriber.
Les mer »
Goldman Sachs to pay $15 million to CFTC for index-swap violationsGoldman Sachs settled charges Monday with the Commodity Futures Trading Commission that it violated standards related to equity index swap transactions....
Les mer »